Novartis - Tekturna: PharmaGossip readers vote

Read all about it here.

Tekturna will be:
	a star product for Novartis. The first antihypertensive for 10 years; what an opportunity!
	A slow burn. It will be a blockbuster, but it will take time. How much time........ Well Dan Vasella will have retired!
	A "problem child". Where does this new type of antihypertensive fit into therapeutic protocols, what are the side efeects etc. etc.
	A dog. It will never recoup the money invested in it. Save the cash for promoting Galvus (er, or maybe not).
Free polls from Pollhost.com